Fatigue is highly prevalent in the general population and is one of the most common side effects of cancer treatment. There is growing evidence that pro-inflammatory cytokines play a role in cancer-related fatigue, although the molecular mechanisms for chronic inflammation and fatigue have not been determined. The current study utilized genome-wide expression microarrays to identify differences in gene expression and associated alterations in transcriptional activity in leukocytes from breast cancer survivors with persistent fatigue (n = 11) and non-fatigued controls (n = 10). We focused on transcription of inflammation-related genes, particularly those responsive to the pro-inflammatory NF-jB transcription control pathway. Further, given the role of glucocorticoids as key regulators of inflammatory processes, we examined transcription of glucocorticoid-responsive genes indicative of potential glucocorticoid receptor (GR) desensitization. Plasma levels of cortisol were also assessed. Consistent with hypotheses, results showed increased expression of transcripts with response elements for NF-jB, and reduced expression of transcripts with response elements for glucocorticoids (p < .05) in fatigued breast cancer survivors. No differences in plasma levels of cortisol were observed. These data indicate that increased activity of pro-inflammatory transcription factors may contribute to persistent cancer-related fatigue and provide insight into potential mechanisms for tonic increases in NF-jB activity, specifically decreased expression of GR anti-inflammatory transcription factors.
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Introduction
Fatigue is highly prevalent in the general population and a common side effect of cancer treatment (Bower et al., 2000; Cella et al., 2001) . Growing evidence suggests an inflammatory basis for fatigue in healthy (Cho et al., 2009 ) and cancer populations (Alexander et al., 2009; Bower et al., 2002 Bower et al., , 2009 Collado-Hidalgo et al., 2006; Orre et al., 2009; Schubert et al., 2007) . The nuclear factor (NF)-jB transcription control pathway plays a key role in controlling expression of pro-inflammatory genes, yet no study has examined whether aberrant activation of NF-jB is associated with fatigue and what molecular processes might permit this activation. One potential mechanism involves reduced functional activity of the glucocorticoid receptor (GR), which inhibits NF-jB and other pro-inflammatory signaling pathways and is thought to contribute to persistent inflammation in chronic stress and other conditions (Cole et al., 2007; Miller et al., 2008b) . In this study, we tested the hypothesis that persistent cancer-related fatigue is associated with: (1) increased transcription of inflammation-related genes, particularly those responsive to the pro-inflammatory NF-jB transcription control pathway; and (2) decreased transcription of glucocorticoid-responsive genes indicative of potential GR desensitization.
Methods

Subjects
Subjects were drawn from a larger project examining immune and behavioral correlates of fatigue in breast cancer survivors (Collado-Hidalgo et al., 2006) . Participants in this study were recruited from the Los Angeles area through tumor registry listings, newspaper advertisements, flyers, and other media coverage. Eligibility criteria included: (1) originally diagnosed with early-stage
